MIAAIM: Prostate Cancer Tissue Microarrays from MGH_VIC

Richard Dzeng of MGH_VIC released this collection of prostate cancer Tissue Microarrays (TMAs) in early 2026. The data serves as a specialized resource for medical imaging research within the field of oncology, specifically focusing on histopathological samples.

Use Cases

• Training computer vision models to detect cancerous cells in TMA images
• Pathological analysis of tissue structures within prostate cancer samples
• Developing automated histological grading systems for prostate oncology

Strengths

• Source institution is MGH_VIC (Massachusetts General Hospital)
• Focuses specifically on Tissue Microarrays (TMAs) for prostate cancer

Limitations

• Lack of documented column headers or metadata schema
• Dataset is labeled as 'Part 1', indicating it is a subset of a larger collection

Provenance

Source

MGH_VIC

Freshness

Updated February 2026.